Arax Advisory Partners’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
Arax Advisory Partners's PRAX Position: Q2 2026 in Review
Arax Advisory Partners increased its Praxis Precision Medicines (PRAX) stake by 342% in Q2 2026, buying an estimated $41.2K and bringing the position to 168 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3179.
Arax Advisory Partners first reported a position in PRAX in Q2 2025 and has held it in 5 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Arax Advisory Partners held 168 shares of Praxis Precision Medicines worth $56.2K as of Q2 2026.
- Arax Advisory Partners bought 130 Praxis Precision Medicines shares in Q2 2026, an estimated $41.2K.
- Praxis Precision Medicines made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3179 holding.
- Arax Advisory Partners first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 5 quarters since.
- 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.